InvestorsHub Logo

BTH

01/24/11 9:35 AM

#5251 RE: biotech_researcher #5249

I highly doubt it.

I doubt they would use future royalty filing/payments as collateral for debt payments and as cash flow to pay off the debt.

They're still well over a year away from getting any product revenues from Ridaforolimus.